Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Portfolio Pulse from Avi Kapoor
Pfizer Inc. (NYSE:PFE) is anticipated to report a Q4 loss of 22 cents per share compared to the previous year's earnings of $1.14 per share, with expected revenue of $14.43 billion versus $24.29 billion in the same quarter last year. The company's shares closed at $27.47. Analysts have recently adjusted Pfizer's price targets, with changes ranging from a downgrade to maintaining ratings but lowering price targets. The most accurate analysts have accuracy rates between 64% and 76%.
January 29, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pfizer is expected to report a Q4 loss and a significant revenue decline. Analysts have adjusted price targets downward, indicating a cautious outlook on the stock.
The anticipated Q4 loss and revenue decline for Pfizer are negative indicators for the stock's performance. Analysts' recent price target adjustments, predominantly downward, reflect concerns about the company's near-term prospects, likely influencing investor sentiment negatively.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100